Wordt geladen...
Are the novel anticoagulants better than warfarin for patients with atrial fibrillation?
Atrial fibrillation (AF) is associated with significant morbidity and mortality related to stroke due to thromboembolism. Several novel oral anticoagulants (NOACs) have been developed that dose-dependently inhibit thrombin or activated factor X (factor Xa). These new agents offer potential advantage...
Bewaard in:
| Gepubliceerd in: | J Thorac Dis |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
AME Publishing Company
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4321074/ https://ncbi.nlm.nih.gov/pubmed/25713732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2015.01.23 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|